3-ethyl-2-methyl-3,4-dihydroquinazolin-4-one
ID: ALA5286541
Max Phase: Preclinical
Molecular Formula: C11H12N2O
Molecular Weight: 188.23
This compound is available for customization.
Associated Items:
ID: ALA5286541
Max Phase: Preclinical
Molecular Formula: C11H12N2O
Molecular Weight: 188.23
Associated Items:
Canonical SMILES: CCn1c(C)nc2ccccc2c1=O
Standard InChI: InChI=1S/C11H12N2O/c1-3-13-8(2)12-10-7-5-4-6-9(10)11(13)14/h4-7H,3H2,1-2H3
Standard InChI Key: UMQKDYHNDQNEBD-UHFFFAOYSA-N
Molfile:
RDKit 2D 14 15 0 0 0 0 0 0 0 0999 V2000 -0.7158 -0.0030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7158 0.8219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4270 1.2383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.1382 0.8219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.1382 -0.0020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4270 -0.4098 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.0037 1.2359 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.7109 0.8201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7109 -0.0049 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.0058 -0.4142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.4245 1.2321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.4245 -0.4169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1382 -0.0049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.0058 -1.2383 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1 2 2 0 2 3 1 0 4 3 2 0 5 4 1 0 1 6 1 0 6 5 2 0 2 7 1 0 7 8 2 0 8 9 1 0 9 10 1 0 1 10 1 0 8 11 1 0 9 12 1 0 12 13 1 0 10 14 2 0 M END
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 188.23 | Molecular Weight (Monoisotopic): 188.0950 | AlogP: 1.72 | #Rotatable Bonds: 1 |
Polar Surface Area: 34.89 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 6.33 | CX LogP: 1.35 | CX LogD: 1.32 |
Aromatic Rings: 2 | Heavy Atoms: 14 | QED Weighted: 0.68 | Np Likeness Score: -1.46 |
1. Sardar A, Ansari A, Gupta S, Sinha S, Pandey S, Rai D, Kumar M, Bhatta RS, Trivedi R, Sashidhara KV.. (2022) Design, synthesis and biological evaluation of new quinazolinone-benzopyran-indole hybrid compounds promoting osteogenesis through BMP2 upregulation., 244 [PMID:36219902] [10.1016/j.ejmech.2022.114813] |
Source(1):